Novavax’s COVID-19 shot authorized in Taiwan for adults

June 23 (Reuters) – Novavax Inc (NVAX.O) said on Thursday it received regulatory authorization in Taiwan for the use of its protein-based COVID-19 vaccine in people aged 18 and older. Taiwan last year …
( read original story …)